Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus
Authors:
- 1 April 2009
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 157 (4) , 771-776
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion ImagingJACC: Cardiovascular Imaging, 2008
- Myocardial perfusion and function: Single photon emission computed tomographyJournal of Nuclear Cardiology, 2007
- Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trialJournal of Nuclear Cardiology, 2007
- A New Generation of Coronary Vasodilators in Stress Perfusion ImagingThe American Journal of Cardiology, 2007
- Tachycardia Caused by A2A Adenosine Receptor Agonists Is Mediated by Direct Sympathoexcitation in Awake RatsThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Cardiovascular Autonomic Neuropathy Due to Diabetes Mellitus: Clinical Manifestations, Consequences, and TreatmentThe Journal of Clinical Endocrinology & Metabolism, 2005
- ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive SummaryCirculation, 2003
- The Association Between Cardiovascular Autonomic Neuropathy and Mortality in Individuals With DiabetesDiabetes Care, 2003
- Mechanism and Pressor Relevance of the Short-Term Cardiovascular and Renin Excitatory Actions of the Selective A2A-Adenosine Receptor AgonistsJournal of Cardiovascular Pharmacology, 1997
- Adenosine increases sympathetic nerve traffic in humans.Circulation, 1991